Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for ...

REGIONAL nodal irradiation in breast cancer showed low recurrence rates after nodal pCR, even when residual breast disease ...

Locoregional recurrence rate of 2.9% overall with no variation across node-defined risk gr ...

Please provide your email address to receive an email when new articles are posted on . Preoperative breast MRI provides no benefit in stage I or II hormone receptor-negative breast cancer. Five-year ...

The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their individual risk following chemotherapy and surgery. These are the findings ...

PTNB before surgery in stage 1 NSCLC patients is linked to higher local-regional recurrence and mortality rates. The study included 2026 patients, with 38.6% undergoing PTNB, showing higher recurrence ...

During a median follow-up of 9.0 years (IQR, 6.6-10.9), IBTR occurred in 320 patients (3.6%). The initial model, based on variables from Sanghani et al, achieved a Harrell's C-index of 0.74.

What was once 25 treatments over five weeks can now often be delivered in 16 treatments, or even as few as five fractions.

Pottstown, Pennsylvania — Illeana Casiano-Vazquez and her husband Sam cherish every minute together. Six years ago, she was diagnosed with triple-negative breast cancer, an aggressive form of the ...

In this study, researchers aimed to characterize the relationship between major depressive disorder, use of antidepressants, and risk of recurrence in breast cancer patients.